CRISPR Gene Editing in Stem Cells

39 128

40. Fonfara, I. et al. (2016) The CRISPR-associated DNA-cleaving
enzyme Cpf1 also processes precursor CRISPR RNA. Nature
532, 517–521
41. Abudayyeh, O.O. et al. (2016) C2c2 is a single-component
programmable RNA-guided RNA-targeting CRISPR effector.
Science 353, aaf5573
42. Ran, F.A. et al. (2013) Double nicking by RNA-guided CRISPR
Cas9 for enhanced genome editing specificity. Cell 154, 1380–
1389
43. Komor, A.C. et al. (2016) Programmable editing of a target base
in genomic DNA without double-stranded DNA cleavage. Nature
533, 420–424
44. Qi, L.S. et al. (2013) Repurposing CRISPR as an RNA-guided
platform for sequence-specific control of gene expression. Cell
152, 1173– 1183
45. Peters, J.M. et al. (2016) A comprehensive, CRISPR-based
functional analysis of essential genes in bacteria. Cell 165,
1493–1506
46. Gilbert, L.A. et al. (2013) CRISPR-mediated modular RNA-
guided regulation of transcription in eukaryotes. Cell 154,
442– 451
47. Gilbert, L.A. et al. (2014) Genome-scale CRISPR-mediated
control of gene repression and activation. Cell 159,
647– 661
48. Konermann, S. et al. (2015) Genome-scale transcriptional acti-
vation by an engineered CRISPR-Cas9 complex. Nature 517,
583– 588
49. Larson, M.H. et al. (2013) CRISPR interference (CRISPRi) for
sequence-specific control of gene expression. Nat. Protoc. 8,
2180–2196
50. Zhao, Y. et al. (2014) Sequence-specific inhibition of microRNA
via CRISPR/CRISPRi system. Sci. Rep. 4, 3943
51. Perez-Pinera, P. et al. (2013) RNA-guided gene activation by
CRISPR-Cas9-based transcription factors. Nat. Methods 10,
973– 976
52. Cheng, A.W. et al. (2013) Multiplexed activation of endogenous
genes by CRISPR-on, an RNA-guided transcriptional activator
system. Cell Res. 23, 1163– 1171
53. Tanenbaum, M.E. et al. (2014) A protein-tagging system for
signal amplification in gene expression and fluorescence imag-
ing. Cell 159, 635–646
54. Chavez, A. et al. (2015) Highly efficient Cas9-mediated transcrip-
tional programming. Nat. Methods 12, 326– 328
55. Chavez, A.et al. (2016) Comparison of Cas9 activators in multiple
species. Nat. Methods 13, 563–567
56. Zalatan, J.G. et al. (2015) Engineering complex synthetic tran-
scriptional programs with CRISPR RNA scaffolds. Cell 160, 339–
350
57. Hilton, I.B. et al. (2015) Epigenome editing by a CRISPR-Cas9-
based acetyltransferase activates genes from promoters and
enhancers. Nat. Biotechnol. 33, 510– 517
58. Kearns, N.A. et al. (2015) Functional annotation of native
enhancers with a Cas9-histone demethylase fusion. Nat. Meth-
ods 12, 401–403
59. Thakore, P.I. et al. (2015) Highly speci fic epigenome editing by
CRISPR-Cas9 repressors for silencing of distal regulatory ele-
ments. Nat. Methods 12, 1143–1149
60. Vojta, A. et al. (2016) Repurposing the CRISPR-Cas9 system
for targeted DNA methylation. Nucleic. Acids Res. 44, 5615–
5628
61. Kearns, N.A. et al. (2014) Cas9 effector-mediated regulation of
transcription and differentiation in human pluripotent stem cells.
Development 141, 219–223
62. Shi, J. et al. (2015) Discovery of cancer drug targets by CRISPR-
Cas9 screening of protein domains. Nat. Biotechnol. 33, 661–
667
63. Korkmaz, G. et al. (2016) Functional genetic screens for
enhancer elements in the human genome using CRISPR-
Cas9. Nat. Biotechnol. 34, 192–198
64. Shalem, O. et al.(2014) Genome-scale CRISPR-Cas9 knockout
screening in human cells. Science 343, 84–87
65. Bernstein, B.E. et al. (2006) A bivalent chromatin structure marks
key developmental genes in embryonic stem cells. Cell125, 315–
326
66. Zhou, Y. et al. (2014) High-throughput screening of a CRISPR/
Cas9 library for functional genomics in human cells. Nature 509,
487–491
67. Chen, S. et al. (2015) Genome-wide CRISPR screen in a mouse
model of tumor growth and metastasis. Cell 160, 1246–1260
68. Parnas, O. et al. (2015) A genome-wide CRISPR screen in
primary immune cells to dissect regulatory networks. Cell 162,
675–686
69. Wong, A.S. et al. (2016) Multiplexed barcoded CRISPR-Cas9
screening enabled by CombiGEM.Proc. Natl. Acad. Sci. U.S.A.
113, 2544–2549
70. Evers, B. et al. (2016) CRISPR knockout screening outperforms
shRNA and CRISPRi in identifying essential genes.Nat. Biotech-
nol. 34, 631– 633
71. Morgens, D.W. et al. (2016) Systematic comparison of CRISPR/
Cas9 and RNAi screens for essential genes. Nat. Biotechnol. 34,
634–636
72. Lane, A.B. et al. (2015) Enzymatically generated CRISPR libraries
for genome labeling and screening. Dev Cell 34, 373–378
73. Friedland, A.E. et al. (2013) Heritable genome editing in C.
elegans via a CRISPR-Cas9 system. Nat. Methods10, 741– 743
74. Bassett, A.R. et al. (2013) Highly efficient targeted mutagenesis
of Drosophila with the CRISPR/Cas9 system. Cell Rep. 4, 220–
228
75. Jao, L.E. et al. (2013) Efficient multiplex biallelic zebrafish genome
editing using a CRISPR nuclease system. Proc. Natl. Acad. Sci.
U.S.A. 110, 13904– 13909
76. Chang, N. et al. (2013) Genome editing with RNA-guided Cas9
nuclease in zebrafish embryos. Cell Res. 23, 465–472
77. Li, W. et al. (2013) Simultaneous generation and germline trans-
mission of multiple gene mutations in rat using CRISPR-Cas
systems. Nat. Biotechnol. 31, 684–686
78. Lv, Q. et al. (2016) Efficient generation of myostatin gene mutated
rabbit by CRISPR/Cas9. Sci. Rep. 6, 25029
79. Yan, Q. et al. (2014) Generation of multi-gene knockout rabbits
using the Cas9/gRNA system. Cell Regen. (Lond). 3, 12
80. Wang, X. et al. (2015) Generation of gene-modified goats target-
ing MSTN and FGF5 via zygote injection of CRISPR/Cas9 sys-
tem. Sci. Rep. 5, 13878
81. Crispo, M. et al. (2015) Effi cient generation of myostatin knock-
out sheep using CRISPR/Cas9 technology and microinjection
into zygotes. PLoS ONE 10, e0136690
82. Zou, Q. et al. (2015) Generation of gene-target dogs using
CRISPR/Cas9 system. J. Mol. Cell Biol. 7, 580–583
83. Wang, K. et al. (2015) Efficient generation of myostatin mutations
in pigs using the CRISPR/Cas9 System. Sci. Rep. 5, 16623
84. Niu, Y. et al. (2014) Generation of gene-modified cynomolgus
monkey via Cas9/RNA-mediated gene targeting in one-cell
embryos. Cell 156, 836–843
85. Wang, H. et al. (2013) One-step generation of mice carrying
mutations in multiple genes by CRISPR/Cas-mediated genome
engineering. Cell 153, 910– 918
86. Yang, H. et al. (2013) One-step generation of mice carrying
reporter and conditional alleles by CRISPR/Cas-mediated
genome engineering. Cell 154, 1370–1379
87. Platt, R.J. et al. (2014) CRISPR-Cas9 knockin mice for genome
editing and cancer modeling. Cell 159, 440– 455
88. Chiou, S.H. et al. (2015) Pancreatic cancer modeling using
retrograde viral vector delivery and in vivo CRISPR/Cas9-medi-
ated somatic genome editing. Genes. Dev. 29, 1576–1585
89. Swiech, L. et al. (2015) In vivo interrogation of gene function in the
mammalian brain using CRISPR-Cas9. Nat. Biotechnol. 33, 102–
106
90. Sanchez-Rivera, F.J. et al. (2014) Rapid modelling of cooperating
genetic events in cancer through somatic genome editing. Nature
516, 428– 431
91. Xue, W. et al. (2014) CRISPR-mediated direct mutation of cancer
genes in the mouse liver. Nature 514, 380–384
Trends in Cell Biology, November 2016, Vol. 26, No. 11 887